Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. Keeping that in mind, here is one stock where you should be greedy instead of fearful and two facing legitimate challenges.

Consensus Price Target: $102.29 (8.8% implied return)

Established through the merger of Tempur-Pedic and Sealy in 2012, Somnigroup (NYSE:SGI) is a bedding manufacturer known for its innovative memory foam mattresses and sleep products

Why Do We Think SGI Will Underperform?

14.3% annual revenue growth over the last five years was slower than its consumer discretionary peers

Capital intensity will likely ramp up in the next year as its free cash flow margin is expected to contract by 1 percentage points

Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Somnigroup’s stock price of $94.04 implies a valuation ratio of 29.2x forward P/E. To fully understand why you should be careful with SGI, check out our full research report (it’s free).

Consensus Price Target: $215.60 (2.5% implied return)

Based in Connecticut, Crane (NYSE:CR) is a diversified manufacturer of engineered industrial products, including fluid handling, and aerospace technologies.

Why Does CR Fall Short?

Products and services are facing significant end-market challenges during this cycle as sales have declined by 5.2% annually over the last five years

Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth

Performance over the past two years was negatively impacted by new share issuances as its earnings per share grew slower than its revenue

Crane is trading at $210.28 per share, or 33.4x forward P/E. Read our free research report to see why you should think twice about including CR in your portfolio, it’s free.

Consensus Price Target: $350.36 (-11.3% implied return)

Founded in the basement of a Boise, Idaho dental office in 1978, Micron (NYSE:MU) is a leading provider of memory chips used in thousands of devices across mobile, data centers, industrial, consumer, and automotive markets.

Why Are We Bullish on MU?

Annual revenue growth of 61.7% over the last two years was superb and indicates its market share increased during this cycle

Projected revenue growth of 103% for the next 12 months is above its two-year trend, pointing to accelerating demand

Earnings growth has massively outpaced its peers over the last five years as its EPS has compounded at 29.2% annually

At $395.02 per share, Micron trades at 9.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.